Invitation to innovation hangout at UiO 9 June: Tomorrow's medicine – advanced therapies, cell therapy, precision medicine and nuclear medicine

The Life Science Growth House - UiO's innovation unit for life sciences, health and technology - and LMI welcome you to an innovation hangout 9 June. This is a new meeting place for academia and industry.

Topic: Tomorrow's medicine – advanced therapies, cell therapy, precision medicine and nuclear medicine

Inspirational talk: Martin Haswell, General Manager, Roche Pharma Norway
Role model talk: Frans Suurs, PhD, Scientia Fellow UiO, Institute for Cancer Research, Oslo University Hospital and Bayer

Time and place: June 9, 2022 5:00 PM–8:00 PM, Forum auditorium, Oslo Science Park

Registration deadline: June 7

Matchmaking between researchers and students and representatives from Roche, Novartis, AbbVie, GE Healthcare, ThermoFisher, Pfizer, MSD and Bristol Myers Squibb that are members of the Pharmaceutical Industry in Norway (LMI). The companies might for example share their experience on the transition from academia to industry or tell if they are open to collaboration, have plans to expand and if so, what competence they are looking for, or if they are open to hire interns.

With this meeting place the Growth House wants to inspire, give self-confidence and knowledge about the innovation process, help researchers and students to build networks and facilitate collaboration between academia and industry that puts more research from UiO to use for the benefit of patients and society.

The programme with speakers and companies that are attending the matchmaking, and registration:

Norunn Torheim
Communications adviser, PhD
Life Science Growth House
University of Oslo
Phone: +47 971 58 537


Page visits: 1119